Supplementary Methods1 from Discovery of BMS-986365, a First-in-Class Dual Androgen Receptor Ligand-Directed Degrader and Antagonist, for the Treatment of Advanced Prostate Cancer

2026 Open access

Read full text
Authors: Surendra Nayak, John D. Norris, Massimo Ammirante, Emily Rychak, Suzanne E. Wardell, Debbie Liao, Brandon Toyama, Raju Kandimalla, Andy Christoforou, Toshiya Tsuji, Ken Liu, Minerva Tran
+19 more Joseph Meiring, Samantha Reiss, Joseph R. Piccotti, Joshua M. Baughman, Celia Fontanillo, Marwa Khater, Deborah S. Mortensen, Brian E. Cathers, Neil Bence, Daniel W. Pierce, Veronique Plantevin-Krenitsky, Dana E. Rathkopf, Joshua D. Hansen, Lawrence G. Hamann, Rama Krishna Narla, Vivek K. Arora, Donald Patrick McDonnell, Mark Rolfe, Shuichan Xu
DOI: 10.1158/1078-0432.31006846
Cited by: 0

Fields of Study & Subjects

Prostate Cancer Treatment and Research Prostate Cancer Diagnosis and Treatment Estrogen and related hormone effects

Publication details

Publication date
6 January 2026